youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,93%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
US$158,79
arrow_upward
+5,25%(+7,92) 1D
US$158,79
0,00% (0,00)
bedtimeAfter hours
Closed: 9 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$152,78
High
US$162,96
Low
US$149,40
Mkt. cap
21,31 ຕື້
Avg. vol.
2,00 ລ້ານ
Volume
3,14 ລ້ານ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,68
Beta
1,67
Shares outstanding
135,29 ລ້ານ
No. of employees
2 ພັນ
Open
US$152,78
High
US$162,96
Low
US$149,40
Mkt. cap
21,31 ຕື້
Avg. vol.
2,00 ລ້ານ
Volume
3,14 ລ້ານ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,68
Beta
1,67
Shares outstanding
135,29 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
The Business Journals
·
6 ຊົ່ວໂມງກ່ອນ
TwinStrand, UW solidify $245 million award in patent dispute
Yahoo Finance
·
18 ຊົ່ວໂມງກ່ອນ
GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability
Yahoo Finance
·
3 ມື້ກ່ອນ
Guardant Health, Inc. (GH) Stock Forecasts
GuruFocus
·
3 ມື້ກ່ອນ
Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Des
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com